pyrroles has been researched along with Lung Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Balanescu, AR; Bhatt, DL; Chen, AS; Citera, G; Connell, CA; Gold, D; Pascual-Ramos, V; Pope, JE; Sawyerr, G; Schulze-Koops, H; Shapiro, AB | 1 |
| Boku, N; Endo, M; Fukutomi, A; Funakoshi, T; Kenmotsu, H; Machida, N; Onozawa, Y; Todaka, A; Tsushima, T; Yamazaki, K; Yasui, H; Yokota, T | 1 |
| Cantrell, W; Elewski, BE; Seminario-Vidal, L | 1 |
| Chen, P; Duan, S; Gan, Y; Jiang, LZ; Li, GY; Wu, SJ; Zhang, J; Zhang, Y; Zhao, SP | 1 |
| Boyle, HJ; Chatté, G; Fléchon, A; Rivoire, M | 1 |
| Gourgoulianis, KI; Kollia, P; Kostikas, K; Papaioannou, AI | 1 |
| Lawson, K | 1 |
2 review(s) available for pyrroles and Lung Diseases
| Article | Year |
|---|---|
Clinical implications for vascular endothelial growth factor in the lung: friend or foe?
Topics: Angiogenesis Inhibitors; Angiopoietins; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Ephrins; Humans; Hypoxia; Indoles; Lung; Lung Diseases; Pleural Diseases; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Transcription, Genetic; Vascular Endothelial Growth Factor A | 2006 |
Is there a therapeutic future for "potassium channel openers'?
Topics: Adenosine Triphosphate; Benzopyrans; Brain Diseases; Cardiovascular Diseases; Cromakalim; Humans; Ion Channel Gating; Lung Diseases; Potassium Channels; Pyrroles; Urinary Bladder Diseases | 1996 |
1 trial(s) available for pyrroles and Lung Diseases
| Article | Year |
|---|---|
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
Topics: Analgesics, Opioid; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Female; Humans; Lung Diseases; Piperidines; Pyrimidines; Pyrroles; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2022 |
4 other study(ies) available for pyrroles and Lung Diseases
| Article | Year |
|---|---|
Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Indoles; Kaplan-Meier Estimate; Lung Diseases; Lymphangitis; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib; Tegafur; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Pulmonary Cryptococcosis in the Setting of Tofacitinib Therapy for Psoriasis.
Topics: Aged; Cryptococcosis; Humans; Lung Diseases; Male; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles | 2015 |
Atorvastatin attenuates inflammatory infiltration and vascular remodeling in lung of hypercholesterolemia rabbits.
Topics: Animals; Atorvastatin; Body Weight; Bronchoalveolar Lavage Fluid; Cell Proliferation; Drug Evaluation, Preclinical; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Interleukin-6; Lipids; Lung; Lung Diseases; Macrophages, Alveolar; Male; NF-kappa B; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Pyrroles; Rabbits; Random Allocation | 2010 |
Lung toxicity in a patient treated with sunitinib.
Topics: Antineoplastic Agents; Humans; Indoles; Lung Diseases; Male; Middle Aged; Pyrroles; Sunitinib | 2012 |